Congratulations to Zhang Jingtian, his paper entitled 'BSA-AIE nanoparticles with boosted ROS generation for immunogenic cell death immunotherapy of multiple myeloma' has been published in Advanced Materials.
AbstractThe main obstacle of
multiple myeloma (MM) therapy is the compromised immune microenvironment, which
leads to MM relapses and extramedullary disease progression. In this study, we
report a novel strategy of enhanced immunogenic cell death (ICD) immunotherapy
with aggregation-induced emission (AIE) photosensitizer-loaded BSA
nanoparticles (referred as BSA/TPA-Erdn), which could activate T cells, convert
the cold tumor to hot, and reverse T cell senescence to restore the immune
microenvironment for MM treatment. Loading AIE photosensitizer into the hydrophobic
domain of BSA proteins significantly immobilizes the molecular geometry, which
massively increases reactive oxygen species (ROS) generation and elicit a
promising ICD immune response. Employing a NOD-SCID IL-2receptor gamma null
mice model with MM patients’ monocytes, we show that BSA/TPA-Erdn could
simulate human DC maturation, activate functional T lymphocytes, and increase
additional polarization and differentiation signals to deliver a promising
immunotherapy performance. Intriguingly, we show for the first time that
BSA/TPA-Erdn could greatly reverse T cell senescence, a main challenge in
treating MM. Additionally, BSA/TPA-Erdn could effectively recruit more
functional T lymphocytes into MM tumor. As a consequence, BSA/TPA-Erdn restored
MM immune microenvironment and shows the best MM tumor eradication performance,
which shall pave new insights for MM treatment in clinical practices.Advanced Materials. (
IF 32.086 ) DOI: 10.1002/adma.202208692
更多